Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accrual, advisor, authentication, automated, Baby, chose, compartment, Condensed, conjunction, consecutive, counterparty, cybersecurity, delegated, dissolution, Eighteen, float, furniture, GB, goodwill, hardware, hypocellular, Importantly, incurrence, inflationary, intolerant, involuntary, ISO, Israel, JAKi, MASH, morale, MRI, OECD, OTC, partnering, passage, preclincial, predominantly, quotation, ratably, RDEC, readout, refractory, Reg, regain, regular, reserve, reserved, Seventeen, software, split, Symptom, TCJA, timetable, TSS, undertook, Unified, unintended, unlisted, UPC, upcoming, visit, westudy
Removed:
aching, adult, advocacy, aggressively, aid, air, alveolar, ASCEND, assistance, assured, attached, BAL, Banc, barrier, Base, blend, blind, breath, breathing, bronchoalveolar, Cadillac, CC, certiorari, character, chart, chemically, Chemokine, Circuit, cleaned, coefficient, Columbia, commerce, complimentary, concentration, concertedly, concomitant, Controller, conversely, cough, cytokine, decided, dedicated, deductibility, defective, defer, define, delivered, delivering, denied, deteriorating, deviation, diarrhea, differential, differentiated, disputed, distance, domestic, double, dry, Edinburgh, emergency, emergent, En, enabling, enjoy, Erosion, Esbriet, exacerbation, excellence, excise, expeditiously, expel, fallen, fatigue, fever, FibroGen, flexibility, functioning, FVC, FYs, glycoprotein, harbor, harvested, Hedging, hiring, hospitalization, hospitalized, hypertension, imbalance, impression, infection, inhalation, inhaler, inhibited, Inspector, Inventiva, investor, isolation, justified, lavage, leader, Liminal, Linkbase, longitudinal, Mayo, measurable, minimizing, misstated, moderate, mouth, myeloid, myofibroblast, NASH, nintedanib, NV, observation, Ofev, OIG, onset, OPN, opportunistically, outbreak, overexpression, overturned, overview, oxygen, parenchymal, path, pathobiology, PDGF, Pearson, Pedersen, peripheral, permeability, permission, persistent, petition, pharmacodynamic, photosensitivity, pirfenidone, plasminogen, pneumonia, polymorphic, powder, predictable, prevalent, profibrotic, Profit, ranging, reevaluate, Rehearing, Reinvestment, release, repealed, reproducible, reshape, resolved, revoked, routine, routinely, scheduled, Secretary, selectively, setback, Shifting, situ, smoking, spiked, spread, stimulate, stimulator, suggested, suspended, taste, Thirty, throat, tight, Topic, tract, transfusion, Trump, unblinded, undergoing, underserved, understand, university, unrelenting, upper, uptake, walk, worker, wound, writ
Filing tables
Filing exhibits
GLTO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statement (Form S-8 No 333-270380) pertaining to the 2020 Equity Incentive Plan and 2022 Inducement Plan of Galecto, Inc.,
(2)
Registration Statement (Form S-8 No 333-262823) pertaining to the 2020 Equity Incentive Plan of Galecto, Inc.,
(3)
Registration Statement (Form S-8 No 333-249852) pertaining to the 2020 Stock Option and Incentive Plan and 2020 Equity Incentive Plan of Galecto, Inc.,
(4)
Registration Statement (Form S-8 No 333-254805) pertaining to the 2020 Equity Incentive Plan of Galecto Inc.,
(5)
Registration Statement (Form S-3 No. 333-260778) of Galecto, Inc.,
of our report dated March 8, 2024, with respect to the consolidated financial statements of Galecto, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2023.
/s/ EY Godkendt Revisionspartnerselskab
Copenhagen, Denmark
March 8, 2024